NEW YORK (GenomeWeb News) – Exact Sciences today reported a sharp increase in its revenues for the third quarter and cut its net loss by two-thirds year over year.

The Madison, Wis.-based molecular diagnostics firm reported total revenues of $1.3 million for the three-month period ended Sept. 30. It brought in product royalty revenues of $9,000 and license fees of $1.2 million, compared to license fees of $337,000 in the third quarter of 2008. In addition, in last year's third quarter the company paid out $1 million in royalty fees.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

May
15
Sponsored by
Tecan

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.

Jun
20
Sponsored by
PerkinElmer

In this webinar, Michael Quail of the R&D Sequencing team at the Wellcome Trust Sanger Institute will provide an expert perspective on library prep for next-generation sequencing.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.